TNFSF10 and neoplasm: There is a continuous need to target the tumor microenvironment by combinatorial strategies consisting of chemotherapeutic drugs and TRAIL, TRAIL and antagonistic antibodies against PD-1 for efficient immunological activation within the tumor microenvironment in xenografted mice.